-
Study aim
-
The effect of anti-inflammatory diets, low carbohydrate portfolio and intermittent fasting on cardiometabolic status and gene expression
-
Design
-
The clinical trial has a control group with randomized and open label on 100 patients with pre-diabetes, which will be used for randomization from the table of random numbers.
-
Settings and conduct
-
In order to carry out the present study, by examining the files of patients referred to the central laboratory of Kermanshah University of Medical Sciences, patients who meet the conditions to enter the study will be invited to the laboratory of the School of Nutritional Sciences and Food Technology
-
Participants/Inclusion and exclusion criteria
-
A total 100 patients with pre-diabetes will be invited according to ADA criteria, aged 18-55 years and BMI ≥25 kg/m2, who consented to participate in the study. Conditions for not including to the study as follow: pregnancy, lactation, suffering from diseases such as autoimmune diseases, thyroid and unstable cardiovascular diseases, diabetes, severe depression (due to the inability to answer the questions) ), mental and mental illnesses, and finally medication use related to the above conditions. patients who refuse to cooperate during the intervention, patients who become unavailable due to migration or any other reason, women who become pregnant during the intervention will be excluded from the study.
-
Intervention groups
-
Participants were randomly divided into 4 groups: 1) calorie restriction (control) (n=25), 2) low carbohydrate portfolio diet group (n=25), 3) intermittent fasting group (n=25) and 4) group anti-inflammatory diet (n=25) will be divided.
-
Main outcome variables
-
Improving glycemic indices and related gene expression including insulin Receptor (INSR), transcription factor 7 like 2 (TCF7L2), PPARG Co-activator 1- α (PGC1-a)